These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11525028)

  • 21. Weekly docetaxel (Taxotere) in patients with metastatic breast cancer.
    Stemmler HJ; Gutschow K; Sommer H; Malekmohammadi M; Kentenich CH; Forstpointner R; Geuenich S; Bischoff J; Hiddemann W; Heinemann V
    Ann Oncol; 2001 Oct; 12(10):1393-8. PubMed ID: 11762809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
    Sato K; Inoue K; Saito T; Kai T; Mihara H; Okubo K; Koh J; Mochizuki H; Tabei T;
    Jpn J Clin Oncol; 2003 Aug; 33(8):371-6. PubMed ID: 14523055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer.
    Ford HE; Yap YS; Miles DW; Makris A; Hall M; Miller L; Harries M; Smith IE; Johnston SR
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):809-15. PubMed ID: 16528527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two cases of advanced and metastatic breast cancers treated by docetaxel in combination with intra-arterial infusion of adriamycin].
    Doihara H; Yoshitomi S; Hino M; Teramoto A; Ishibe Y; Ogasawara Y; Nagahiro I; Sano Y; Shimizu N
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):229-33. PubMed ID: 11242652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
    Taguchi T; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1915-24. PubMed ID: 9797814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.
    Mey U; Gorschlüter M; Ziske C; Kleinschmidt R; Glasmacher A; Schmidt-Wolf IG
    Anticancer Drugs; 2003 Mar; 14(3):233-8. PubMed ID: 12634618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
    Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
    Wada Y; Otoshi M; Jitsuko A; Nishikawa H; Takahara S; Tsubono M; Imai S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1041-5. PubMed ID: 17637539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
    ten Bokkel Huinink WW; Prove AM; Piccart M; Steward W; Tursz T; Wanders J; Franklin H; Clavel M; Verweij J; Alakl M
    Ann Oncol; 1994 Jul; 5(6):527-32. PubMed ID: 7918124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
    Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer.
    Oishi T; Kigawa J; Fujiwara K; Fujiwara M; Numa F; Aotani E; Katsumata N; Kohno I; Kato H; Terakawa N;
    Gynecol Oncol; 2003 Aug; 90(2):421-4. PubMed ID: 12893211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast cancer with liver metastasis responsive to docetaxel: case report].
    Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):743-6. PubMed ID: 9571974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two cases of recurrent breast cancer successfully treated with paclitaxel weekly therapy].
    Tagaya N; Nakagawa A; Okada T; Hamada K; Mikami H; Ito S; Kubota K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1479-83. PubMed ID: 14584281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
    Taguchi T
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.
    Blaney SM; Seibel NL; O'Brien M; Reaman GH; Berg SL; Adamson PC; Poplack DG; Krailo MD; Mosher R; Balis FM
    J Clin Oncol; 1997 Apr; 15(4):1538-43. PubMed ID: 9193350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.